| Dr Brandon Ellis Prioreschi, MD | |
|
512 Saybrook Rd Ste 100, Middletown, CT 06457-4788 | |
| (860) 347-7636 | |
| Not Available |
| Full Name | Dr Brandon Ellis Prioreschi |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 12 Years |
| Location | 512 Saybrook Rd Ste 100, Middletown, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659638948 | NPI | - | NPPES |
| 1659638948 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 71106 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Middlesex Hospital | Middletown, CT | Hospital |
| Midstate Medical Center | Meriden, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopaedic And Neurosurgery Specialists, Pllc | 5294628947 | 208 |
| Ptsma Inc | 7911800180 | 92 |
| Select Physical Therapy Of Connecticut Limited Partnership | 9638080625 | 11 |
News Archive
Seaside Therapeutics, Inc. announced today data from the largest randomized, placebo-controlled study conducted to date in individuals with fragile X syndrome. In a Phase 2 study of STX209, clinically meaningful improvements on global and specific neurobehavioral outcomes were observed in the general study population. The improvements were statistically significant in pediatric patients with more severe impairments in sociability - a core symptom of fragile X syndrome.
As rescue workers scramble to provide assistance to hundreds of thousands of people following Haiti's earthquake, Earth observation satellite data continues to provide updated views of the situation on the ground.
1st International Symposium on Deuterium Depletion was held on 13-14 May 2010 in Budapest, Hungary. The conference programme focused on the advances in the research and clinical application of deuterium depletion, its present and future role in anticancer research and oncotherapy, diabetes research and anti-aging.
Three faculty with Lehigh University's College of Education recently received research funding from the Institute of Education Sciences (IES), the arm of the U.S. Department of Education that supports research, statistics and evaluation to ground education practice and policy.
A study performed at the University of São Paulo's Biomedical Science Institute (ICB-USP) in Brazil shows that sofosbuvir, a drug used to treat chronic hepatitis C, is capable of eliminating chikungunya virus and yellow fever virus.
› Verified 9 days ago
| Entity Name | Orthopaedic & Neurosurgery Specialists, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033318720 PECOS PAC ID: 5294628947 Enrollment ID: O20040205000859 |
News Archive
Seaside Therapeutics, Inc. announced today data from the largest randomized, placebo-controlled study conducted to date in individuals with fragile X syndrome. In a Phase 2 study of STX209, clinically meaningful improvements on global and specific neurobehavioral outcomes were observed in the general study population. The improvements were statistically significant in pediatric patients with more severe impairments in sociability - a core symptom of fragile X syndrome.
As rescue workers scramble to provide assistance to hundreds of thousands of people following Haiti's earthquake, Earth observation satellite data continues to provide updated views of the situation on the ground.
1st International Symposium on Deuterium Depletion was held on 13-14 May 2010 in Budapest, Hungary. The conference programme focused on the advances in the research and clinical application of deuterium depletion, its present and future role in anticancer research and oncotherapy, diabetes research and anti-aging.
Three faculty with Lehigh University's College of Education recently received research funding from the Institute of Education Sciences (IES), the arm of the U.S. Department of Education that supports research, statistics and evaluation to ground education practice and policy.
A study performed at the University of São Paulo's Biomedical Science Institute (ICB-USP) in Brazil shows that sofosbuvir, a drug used to treat chronic hepatitis C, is capable of eliminating chikungunya virus and yellow fever virus.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brandon Ellis Prioreschi, MD 512 Saybrook Rd Ste 100, Middletown, CT 06457-4788 Ph: () - | Dr Brandon Ellis Prioreschi, MD 512 Saybrook Rd Ste 100, Middletown, CT 06457-4788 Ph: (860) 347-7636 |
News Archive
Seaside Therapeutics, Inc. announced today data from the largest randomized, placebo-controlled study conducted to date in individuals with fragile X syndrome. In a Phase 2 study of STX209, clinically meaningful improvements on global and specific neurobehavioral outcomes were observed in the general study population. The improvements were statistically significant in pediatric patients with more severe impairments in sociability - a core symptom of fragile X syndrome.
As rescue workers scramble to provide assistance to hundreds of thousands of people following Haiti's earthquake, Earth observation satellite data continues to provide updated views of the situation on the ground.
1st International Symposium on Deuterium Depletion was held on 13-14 May 2010 in Budapest, Hungary. The conference programme focused on the advances in the research and clinical application of deuterium depletion, its present and future role in anticancer research and oncotherapy, diabetes research and anti-aging.
Three faculty with Lehigh University's College of Education recently received research funding from the Institute of Education Sciences (IES), the arm of the U.S. Department of Education that supports research, statistics and evaluation to ground education practice and policy.
A study performed at the University of São Paulo's Biomedical Science Institute (ICB-USP) in Brazil shows that sofosbuvir, a drug used to treat chronic hepatitis C, is capable of eliminating chikungunya virus and yellow fever virus.
› Verified 9 days ago
Dr. Michael A Kuhn, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 512 Saybrook Rd, Suite 100, Middletown, CT 06457 Phone: 860-347-7636 Fax: 860-894-1802 | |
Dr. Joseph M. Sohn, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 410 Saybrook Rd, Suite 100, Middletown, CT 06457 Phone: 860-685-8951 Fax: 860-685-8945 | |
Dr. Alfred K Hicks Jr., D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 512 Saybrook Rd, Ste 100, Middletown, CT 06457 Phone: 860-347-7636 | |
Lawrence Berson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 410 Saybrook Rd, Suite 100, Middletown, CT 06457 Phone: 860-685-8940 | |
Sean J O'donnell, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 410 Saybrook Rd, Middletown, Middletown, CT 06457 Phone: 860-685-8940 | |
Jeffrey A Bash, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 410 Saybrook Rd, Suite 100, Middletown, CT 06457 Phone: 860-685-8940 | |
Dr. Ryan Andrew Naujoks, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 512 Saybrook Rd, Middletown, CT 06457 Phone: 860-347-7636 |